Dabigatran Etexilate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06695 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | sclerosing cholangitis | KG + DL |
| 2 | obsolete familial combined hyperlipidemia | KG + DL |
| 3 | hypoalphalipoproteinemia | KG + DL |
| 4 | homozygous familial hypercholesterolemia | KG + DL |
| 5 | primary release disorder of platelets | KG + DL |
| 6 | Glanzmann thrombasthenia | KG + DL |
| 7 | gout | KG + DL |
| 8 | pseudo-von Willebrand disease | KG + DL |
| 9 | rheumatoid arthritis | KG + DL |
| 10 | HIV infectious disease | KG + DL |
| 11 | female breast carcinoma | KG + DL |
| 12 | endocarditis | KG + DL |
| 13 | hemoglobinopathy | KG + DL |
| 14 | obsolete susceptibility to ischemic stroke | KG + DL |
| 15 | cholecystolithiasis | KG + DL |
| 16 | endocardial fibroelastosis | KG + DL |
| 17 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 18 | simian immunodeficiency virus infection | KG + DL |
| 19 | feline acquired immunodeficiency syndrome | KG + DL |
| 20 | hypolipoproteinemia (disease) | KG + DL |
| 21 | obsolete hyperuricemia (disease) | KG + DL |
| 22 | paratenonitis | KG + DL |
| 23 | beta-thalassemia with other manifestations | KG + DL |
| 24 | calcific tendinitis | KG + DL |
| 25 | pyropoikilocytosis, hereditary | KG + DL |
| 26 | myelodysplastic syndrome | KG + DL |
| 27 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 28 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 29 | myositis | KG + DL |
| 30 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 31 | refractory cytopenia of childhood | KG + DL |
| 32 | unclassified myelodysplastic syndrome | KG + DL |
| 33 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 34 | partial deletion of the long arm of chromosome 5 | KG + DL |
| 35 | aregenerative anemia | KG + DL |
| 36 | severe congenital hypochromic anemia with ringed sideroblasts | KG + DL |
| 37 | pyruvate kinase deficiency of red cells | KG + DL |
| 38 | brachydactyly-syndactyly syndrome | KG + DL |
| 39 | pneumocystosis | KG + DL |
| 40 | autosomal dominant macrothrombocytopenia | KG + DL |
| 41 | diabetic nephropathy | KG + DL |
| 42 | malignant pleural mesothelioma | KG + DL |
| 43 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 44 | infectious otitis media | KG + DL |
| 45 | chronic hepatitis B virus infection | KG + DL |
| 46 | oral candidiasis | KG + DL |
| 47 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
| 48 | sickle cell-hemoglobin d disease syndrome | KG + DL |
| 49 | sickle cell-hemoglobin E disease syndrome | KG + DL |
| 50 | sickle cell-beta-thalassemia disease syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.